CLAIM CARD
Across the synthesis, cross-study disagreements were identified between studies—predominantly in the contextual-other outcome class—reflecting the reality that mechanistic plausibility for senescence-targeted therapeutics coexists with sparse and inconsistent human-RCT evidence, leaving boundary conditions for clinical translation.
Evidence grade: exploratory
Contradiction status: none
Publication: ec49b21a-665d-471c-b2c4-8ab5a5943e34
Provenance: Derivation Web chain
Citation Support
source_1Murray 2025source_2Mielke 2025source_3Zumerle 2024source_4Mury 2025source_5Zhao 2024